| Pharmacologic management of neuropathic pain: evidence-based recommendations RH Dworkin, AB O’connor, M Backonja, JT Farrar, NB Finnerup, ... Pain 132 (3), 237-251, 2007 | 2819 | 2007 |
| Recommendations for the pharmacological management of neuropathic pain: an overview and literature update RH Dworkin, AB O'Connor, J Audette, R Baron, GK Gourlay, ML Haanpää, ... Mayo Clinic Proceedings 85 (3), S3-S14, 2010 | 1716 | 2010 |
| Treatment of neuropathic pain: an overview of recent guidelines AB O'Connor, RH Dworkin The American journal of medicine 122 (10), S22-S32, 2009 | 1016 | 2009 |
| Pain associated with multiple sclerosis: systematic review and proposed classification AB O’Connor, SR Schwid, DN Herrmann, JD Markman, RH Dworkin PAIN® 137 (1), 96-111, 2008 | 617 | 2008 |
| Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy AB O’Connor Pharmacoeconomics 27, 95-112, 2009 | 563 | 2009 |
| Interventional management of neuropathic pain: NeuPSIG recommendations RH Dworkin, AB O’Connor, J Kent, SC Mackey, SN Raja, BR Stacey, ... PAIN® 154 (11), 2249-2261, 2013 | 467 | 2013 |
| Treatment considerations for elderly and frail patients with neuropathic pain KE Schmader, R Baron, ML Haanpää, J Mayer, AB O'Connor, ASC Rice, ... Mayo Clinic Proceedings 85 (3), S26-S32, 2010 | 102 | 2010 |
| Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster RH Dworkin, R White, AB O'Connor, O Baser, K Hawkins Journal of the American Geriatrics Society 55 (8), 1168-1175, 2007 | 90 | 2007 |
| Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations SM Smith, RH Dworkin, DC Turk, MP McDermott, C Eccleston, JT Farrar, ... Pain 161 (11), 2446-2461, 2020 | 82 | 2020 |
| International association for the study of pain neuropathic pain special interest group. Interventional management of neuropathic pain: NeuPSIG recommendations RH Dworkin, AB O’Connor, J Kent, SC Mackey, SN Raja, BR Stacey, ... Pain 154 (11), 2249-2261, 2013 | 76 | 2013 |
| Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations SD Comer, JP Zacny, RH Dworkin, DC Turk, GE Bigelow, RW Foltin, ... PAIN® 153 (12), 2315-2324, 2012 | 71 | 2012 |
| The need for improved access to FDA reviews AB O’Connor JAMA 302 (2), 191-193, 2009 | 54 | 2009 |
| A cost-utility comparison of four first-line medications in painful diabetic neuropathy AB O’Connor, K Noyes, RG Holloway Pharmacoeconomics 26, 1045-1064, 2008 | 54 | 2008 |
| Eliminating analgesic meperidine use with a supported formulary restriction AB O’Connor, VJ Lang, TE Quill The American journal of medicine 118 (8), 885-889, 2005 | 52 | 2005 |
| Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations AB O’Connor, DC Turk, RH Dworkin, NP Katz, R Colucci, ... PAIN® 154 (11), 2324-2334, 2013 | 51 | 2013 |
| Building comparative efficacy and tolerability into the FDA approval process AB O’Connor Jama 303 (10), 979-980, 2010 | 48 | 2010 |
| Health care expenditure burden of persisting herpes zoster pain RH Dworkin, R White, AB O'Connor, K Hawkins Pain Medicine 9 (3), 348-353, 2008 | 45 | 2008 |
| Association of pain score documentation and analgesic use in a pediatric emergency department KM Kellogg, RJ Fairbanks, AB O’Connor, CO Davis, MN Shah Pediatric emergency care 28 (12), 1287-1292, 2012 | 41 | 2012 |
| Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis AB O’Connor, FL Zwemer, DP Hays, C Feng Academic Emergency Medicine 16 (6), 477-487, 2009 | 41 | 2009 |
| Internal medicine residency program director burnout and program director turnover: results of a national survey AB O'Connor, AJ Halvorsen, JM Cmar, KM Finn, KE Fletcher, L Kearns, ... The American Journal of Medicine 132 (2), 252-261, 2019 | 39 | 2019 |
